Mydekla (Daclatasvir)

Facts of MYDEKLA

  • Brand Name: MYDEKLA
  • Medicine Name: Daclatasvir
  • Company Name: Mylan Pharma.
  • Supplied as: 28 tablets of 60mg
Get Price

Description

What is MYDEKLA ™?

MYDEKLA is indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.

What is the best price of MYDEKLA?

Please contact  Tollfree – +91 1800 889 1064+91 8130290915 for MYDEKLA price in India We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Where can I Buy MYDEKLA?

The Indian Pharma connects buyer with the supplier who can ship MYDEKLA to any country of the world as per the buyer’s requirement and Government regulations of the country. MYDEKLA is manufactured by Mylan Pharma.

The Indian Pharma provides options of choosing exporter and supplier of cancer treatment medicines. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Availability

Is MYDEKLA available in India?

MYDEKLA is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

You can access medicine in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)

We facilitate by providing:

  • Medicine Price.
  • Finding Genuine and reliable source
  • Ensuring 100% transparency.

MYDEKLA can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of MYDEKLA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

How order will be confirmed?

The order will be confirmed only after the receipt of

  • Valid prescription of Clinician
  • Import permit if applicable

Send your inquiry to find MYDEKLA™ (Daclatasvir) in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

Drugs Approved for Hepatitis C

  •  Velpanat (Sofosbuvir + Velpatasvir)
  • MYHEP ALL (Sofosbuvir + Velpatasvir)
  • VELASOF (Sofosbuvir + Velpatasvir)
  • HEPCVIR L (Sofosbuvir + Ledipasvir)
  • SOVIHEP V (Sofosbuvir + Velpatasvir)
  • HEPCINAT LP (Sofosbuvir + Ledipasvir)
  • MYHEP LVIR (Sofosbuvir + Ledipasvir)
  • LEDIFOS (Sofosbuvir + Ledipasvir)
  • LEDIHEP (Sofosbuvir + Ledipasvir)
  • Hepcinat (Sofosbuvir)
  • HEPCVIR (Sofosbuvir)
  • SOVIHEP (Sofosbuvir)
  • DACLAHEP (Daclatasvir)
  • NATDAC (Daclatasvir)
×